Trial intelligence / Profile preview

Sildenafil for COVID-19 with Perfusion Mismatch

NCT04489446Phase 2Completed

Sponsor
Universidad Andrés Bello
Start
Aug 2020
Primary completion
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ASP-001 in coronavirus disease 2019 (COVID-19), sponsored by Universidad Andrés Bello. Started Aug 2020; status: completed.

02

Drugs

ASP-001
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04489446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04489446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call